Articles with public access mandates - Tiziano TuccinardiLearn more
Not available anywhere: 14
Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor β
F Minutolo, S Bertini, C Granchi, T Marchitiello, G Prota, S Rapposelli, ...
Journal of medicinal chemistry 52 (3), 858-867, 2009
Mandates: US National Institutes of Health
Rational Design, Synthesis, and Pharmacological Properties of New 1,8-Naphthyridin-2(1H)-on-3-Carboxamide Derivatives as Highly Selective Cannabinoid-2 …
C Manera, G Saccomanni, B Adinolfi, V Benetti, A Ligresti, MG Cascio, ...
Journal of medicinal chemistry 52 (12), 3644-3651, 2009
Mandates: US National Institutes of Health
Synthesis, modeling, and RET protein kinase inhibitory activity of 3-and 4-substituted β-carbolin-1-ones
R Cincinelli, G Cassinelli, S Dallavalle, C Lanzi, L Merlini, M Botta, ...
Journal of medicinal chemistry 51 (24), 7777-7787, 2008
Mandates: US National Institutes of Health
Studies on the ATP binding site of Fyn kinase for the identification of new inhibitors and their evaluation as potential agents against tauopathies and tumors
C Tintori, G La Sala, G Vignaroli, L Botta, AL Fallacara, F Falchi, M Radi, ...
Journal of Medicinal Chemistry 58 (11), 4590-4609, 2015
Mandates: European Commission, Government of Italy
Synthesis and Photophysical Properties of 3-Amino-4-arylpyridin-2 (1Н)-ones
AL Shatsauskas, AA Abramov, SA Chernenko, AS Kostyuchenko, ...
Synthesis 52 (02), 227-238, 2020
Mandates: National Natural Science Foundation of China
Pyrazolylbenzo [d] imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII
S Kumar, M Ceruso, T Tuccinardi, CT Supuran, PK Sharma
Bioorganic & Medicinal Chemistry 24 (13), 2907-2913, 2016
Mandates: European Commission
New Resorcinol− Anandamide “Hybrids” as Potent Cannabinoid Receptor Ligands Endowed with Antinociceptive Activity in Vivo
A Brizzi, V Brizzi, MG Cascio, F Corelli, F Guida, A Ligresti, S Maione, ...
Journal of medicinal chemistry 52 (8), 2506-2514, 2009
Mandates: US National Institutes of Health
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)
G Bononi, G Poli, F Rizzolio, T Tuccinardi, M Macchia, F Minutolo, ...
Expert opinion on therapeutic patents 31 (2), 153-168, 2021
Mandates: Government of Italy
A virtual screening study for lactate dehydrogenase 5 inhibitors by using a pharmacophore‐based approach
T Tuccinardi, G Poli, I Corchia, C Granchi, M Lapillo, M Macchia, ...
Molecular informatics 35 (8-9), 434-439, 2016
Mandates: US National Institutes of Health
Metalloprotease inhibitor profiles of human ADAM8 in vitro and in cell-based assays
U Schlomann, K Dorzweiler, E Nuti, T Tuccinardi, A Rossello, JW Bartsch
Biological Chemistry 400 (6), 801-810, 2019
Mandates: German Research Foundation
Study of the binding interaction between fluorinated matrix metalloproteinase inhibitors and Human Serum Albumin
G Digilio, T Tuccinardi, F Casalini, C Cassino, DM Dias, CFGC Geraldes, ...
European journal of medicinal chemistry 79, 13-23, 2014
Mandates: Fundação para a Ciência e a Tecnologia, Portugal, European Commission …
Modification on the 1, 2-dihydro-2-oxo-pyridine-3-carboxamide core to obtain multi-target modulators of endocannabinoid system
F Gado, C Arena, C La Fauci, I Reynoso-Moreno, S Bertini, M Digiacomo, ...
Bioorganic chemistry 94, 103353, 2020
Mandates: Government of Italy
N-aryl-N′-ureido-O-sulfamates as potent and selective inhibitors of hCA VB over hCA VA: Deciphering the binding mode of new potential agents in mitochondrial dysfunctions
G Poli, M Bozdag, E Berrino, A Angeli, T Tuccinardi, F Carta, CT Supuran
Bioorganic Chemistry 100, 103896, 2020
Mandates: Government of Italy
A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitor
M Adeel, G Saorin, G Boccalon, AA Sfriso, S Parisi, I Moro, S Palazzolo, ...
International Journal of Pharmaceutics 613, 121374, 2022
Mandates: Government of Italy
Available somewhere: 60
The history of nanoscience and nanotechnology: from chemical–physical applications to nanomedicine
S Bayda, M Adeel, T Tuccinardi, M Cordani, F Rizzolio
Molecules 25 (1), 112, 2019
Mandates: AIRC Foundation for Cancer Research in Italy
Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor
CH Wong, L Nguyen, J Peh, LM Luu, JS Sanchez, SL Richardson, ...
Journal of the American Chemical Society 136 (17), 6355-6361, 2014
Mandates: US National Institutes of Health
The TRPA 1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives
R Nassini, C Fusi, S Materazzi, E Coppi, T Tuccinardi, IM Marone, ...
British journal of pharmacology 172 (13), 3397-3411, 2015
Mandates: Government of Italy
The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: interplay with the complex tumor microenvironment and novel therapeutic strategies
B El Hassouni, C Granchi, A Vallés-Martí, IGP Supadmanaba, G Bononi, ...
Seminars in cancer biology 60, 238-248, 2020
Mandates: Dutch Cancer Society, AIRC Foundation for Cancer Research in Italy
Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy
S Bayda, M Hadla, S Palazzolo, V Kumar, I Caligiuri, E Ambrosi, ...
Journal of Controlled Release 248, 144-152, 2017
Mandates: Government of Italy
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity
E Nuti, AR Cantelmo, C Gallo, A Bruno, B Bassani, C Camodeca, ...
Journal of Medicinal Chemistry 58 (18), 7224-7240, 2015
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program